Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

NCT03654833 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma, Malignant

Interventions

DRUG: Rucaparib
DRUG: Abemaciclib
DRUG: pembrolizumab & bemcentinib
DRUG: Atezolizumab & Bevacizumab
DRUG: Dostarlimab and Niraparib

Sponsor

University of Leicester

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]